Transitional care for pediatric cardiomyopathy patients in Japan: A nationwide survey of current practices and

Keiichi Hirono1, Kaori Tsuboi1, Mako Okabe1

  • 1Department of Pediatrics, Faculty of Medicine, University of Toyama, Toyama, Japan.

Journal of Cardiology
|June 23, 2026
PubMed

Insights

Transitional care for pediatric cardiomyopathy in Japan is underdeveloped, with few programs and insufficient education. System improvements and disease-specific frameworks are urgently needed for better patient outcomes.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Healthcare Systems

Background:

  • Pediatric cardiomyopathy requires lifelong follow-up, making transitional care crucial as survival rates improve.
  • The status of transitional care for pediatric cardiomyopathy patients in Japan is not well-defined.
  • Effective transition from pediatric to adult services is vital for long-term patient management.

Purpose of the Study:

  • To assess the current state of transitional care for pediatric cardiomyopathy in Japan.
  • To identify challenges, educational needs, and system improvements required for effective transitional care.
  • To compare transitional care practices across different institution types.

Main Methods:

  • Nationwide cross-sectional questionnaire survey of institutions in the Japanese Society of Pediatric Cardiology and Cardiac Surgery.
  • Survey focused on transitional care practices, challenges, education, and system needs.
  • Data analyzed to identify trends and differences based on institution characteristics.

Main Results:

  • Only 12.1% of institutions have operational transitional care programs; 27.3% reported no patient transitions in five years.
  • Over 90% of respondents found education and training insufficient.
  • Difficult transitions were linked to multiple anomalies, intellectual disability, and patient knowledge gaps, with variations based on institution volume and services.

Conclusions:

  • Transitional care for pediatric cardiomyopathy in Japan is significantly underdeveloped compared to guidelines.
  • There are substantial gaps in current practices, education, and system support.
  • Cardiomyopathy-specific transition frameworks, enhanced education, and policy changes are urgently required.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...